Keywords: acadia, initiates, ph, iib, trial, acp-104, usa

Acadia initiates Ph IIb trial of ACP-104

Article | 02 July 2007

Print This

The USA's Acadia Pharmaceuticals has initiated a Phase IIb trial designed to evaluate the safety and efficacy of its atypical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in